1. Alcalá M, Vivas NM, Hospital S et al (2003) Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids. Neuropharmacology 44:749–755
2. Alzheimer’s Association (n.d.) FDA-Approved Treatment for Alzheimer’s. http://www.alz.org
3. Ashani Y, Peggins JO, Doctor BP (1992) Mechanism of inhibition of cholinesterases by Huperzine A. (Reannouncement with new availability information). No. AD-A-254440/1/XAB. Walter Reed Army Inst. of Research, Washington, DC
4. Bai DL, Tang XC, He XC (2000) Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease. Curr Med Chem 7(3):355–374
5. Batsch NL, Mittelman MS, Alzheimer’s Disease International (2012) World Alzheimer Report 2012: overcoming the stigma of dementia. Alzheimer’s Disease International, London, UK